fig2

Evolving trends and drug class dynamics in drug-induced fatty liver disease over two decades

Figure 2. Reported cases of DIFLD associated with various drug classes from the FAERS database (2004-2023). The bar chart on the left represents the top 50 drugs linked to DIFLD cases, categorized by drug class. The donut chart on the right shows the distribution of DIFLD cases among the drug classes. We confirm that the figure is original and does not require external copyright permission. DIFLD: Drug-induced fatty liver disease; FAERS: Food and Drug Administration’s Adverse Event Reporting System; DMARDs: disease-modifying antirheumatic drugs; NSAIDs: nonsteroidal anti-inflammatory drugs; INF: interferon.

Metabolism and Target Organ Damage
ISSN 2769-6375 (Online)
Follow Us

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/